Samba Sensors AB and Raumedic AG initiate catheter collaboration

Affärsstrategerna's subsidiary Samba Sensors AB, Sweden and Raumedic
AG, Germany, have initiated business collaboration with the aim of
developing new and innovative catheter systems for clinical use. The
parties intend to seek common business opportunities related to
catheters that combine Samba Sensors' unique fiber-optic pressure
monitoring technology and Raumedic's vast state-of-the-art
capabilities in catheter design and manufacturing."Raumedic is an ideal partner for us since the company possesses all
the frontline competence and resources needed to integrate our
technology into truly innovative pressure catheters. In addition they
can provide first-class manufacturing capacity and facilities for
large scale production", says Lennart Nilsson, President of Samba
Sensors AB.

 'Samba Sensors' ultra-miniature pressure sensing technology will
allow Raumedic to pursue new exciting business opportunities in the
high-tech catheter segments. Through collaboration with Samba Sensors
we foresee smaller, smarter and more competitive pressure catheters
in Raumedic's portfolio in the future", comments Dr. Christian von
Falkenhausen, Director of R&D at Raumedic AG."We see big commercial possibilities through this collaboration" says
Claes-Göran Fridh, CEO Affärsstrategerna AB.

SAMBA SENSORS (www.samba.se) is a world leading developer and
manufacturer of advanced fiber-optic technology for pressure
measurements. Company expertise is focused today on the design,
development and marketing of ultra-miniature pressure transducers and
control systems, primarily for applications in the life sciences.

RAUMEDIC (www.raumedic.com) is a worldwide development partner and
system supplier to the medical and pharmaceutical industry. Supported
by in-house R&D as well as Engineering department, Raumedic develops
and manufactures innovative, high-quality, customer specific products
in all common polymers and elastomers at its head-office in
Münchberg/Bavaria and its manufacturing locations in Feuchtwangen and
Zwönitz.
Raumedic's high innovative multi parameter sensor (pressure, oxygen,
temperature) is already well established in the field of
neuromonitoring.

AFFÄRSSTRATEGERNA (www.astrateg.se) listed at OMX Nordic Exchange
Stockholm is a venture capital company investing in value-added
capital in companys with large growth potential and good prospects of
becoming a world-leading niche company. In addition Affärsstrategerna
invests in mature and profitable companys. Some of the companys in
the portfolio are: A3TL, AlphaHelix M.D., Innate Pharmaceuticals,
M.O.R.E. Invest, Munax, Naty, Photometric, Samba Sensors, SchoolSoft
and Starlounge.


Contacts

Samba Sensors AB
Gruvgatan 6
421 30 Göteborg
Sweden

Contact person:

Lennart Nilsson,President
Phn: +46-(0)31 704 9160
Email: lennart.nilsson@samba.se


Raumedic AG
Hermann-Staudinger-Str. 2
DE-95233  Helmbrechts
Germany


Contact person:

Dr. Christian von Falkenhausen, Director of R&D
Phn: +49-(0)9252 359 1739
Email: christian.von.falkenhausen@raumedic.com

Affärsstrategerna AB
Artillerigatan 6
114 51 Stockholm
Sweden

Contact person:

Claes-Göran Fridh
CEO, Affärsstrategerna AB
Phn: +468-545 831 95
Mob: +46 708 66 24 03
E-mail: cgfridh@astrateg.se
www.astrateg.se